Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer.

Journal of Korean medical science - 1 Jun 2007

Na Im Il, Rho Jin Kyung, Choi Yun Jung, Kim Cheol Hyeon, Koh Jae Soo, Ryoo Baek-Yeol, Yang Sung Hyun, Lee Jae Cheol

Abstract excerpt

The aim of the current study was to determine the clinical significance according to the subtypes of epidermal growth factor receptor (EGFR) mutations and presence of KRAS mutations in operable non-small-cell lung cancer (NSCLC). We sequenced exons 18-21 of the EGFR tyrosine kinase domain and exa...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Disease-Free Survival
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Share to Sex Factors

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 17596643
DOI: 10.3346/jkms.2007.22.3.393
PMCID: PMC2693627

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17596643-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer.PMID 17596643Read ↗

Prognostic implication of EGFR mutation status and subtype in resected lung adenocarcinoma patients irrespective of therapy.Semantic proximity Read ↗

Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.Semantic proximity Read ↗

Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas.Semantic proximity Read ↗

EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.Semantic proximity Read ↗

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.Semantic proximity Read ↗

Impact of smoking status and pathologic type on epidermal growth factor receptor mutations in lung cancer.Semantic proximity Read ↗

Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.Semantic proximity Read ↗

Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.Semantic proximity Read ↗

Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.Semantic proximity Read ↗

EGFR and KRAS mutations in patients with adenocarcinoma of the lung.Semantic proximity Read ↗

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the LungSemantic proximity Read ↗

Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.